Factors determining the size frequency distribution of beta-amyloid (A beta) deposits in Alzheimer's disease

被引:6
|
作者
Armstrong, RA
Myers, D
Smith, CUM
机构
[1] Vision Sciences, Aston University
关键词
D O I
10.1006/exnr.1997.6465
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The size frequency distributions of discrete -amyloid (A1P) deposits were studied in single sections of the temporal lobe from patients with Alzheimer's disease. The size distributions were unimodal and positively skewed. In 18/25 (72%) tissues examined, a log normal distribution was a good fit to the data. This suggests that the abundances of deposit sizes are distributed randomly on a log scale about a mean value. Three hypotheses were proposed to account for the data: (1) sectioning in a single plane, (2) growth and disappearance of A beta deposits, and (3) the origin of A beta deposits from clusters of neuronal cell bodies. Size distributions obtained by serial reconstruction through the tissue were similar to those observed in single sections, which would not support the first hypothesis. The log normal distribution of A beta deposit size suggests a model in which the rate of growth of a deposit is proportional to its volume. However, mean deposit size and the ratio of large to small deposits were not positively correlated with patient age or disease duration. The frequency distribution of A beta deposits which were closely associated with 0, 1, 2, 3, or more neuronal cell bodies deviated significantly from a log normal distribution, which would not support the neuronal origin hypothesis. On the basis of the present data, growth and resolution of A beta deposits would appear to be the most likely explanation for the log normal size distributions. (C) 1997 Academic Press.
引用
收藏
页码:574 / 579
页数:6
相关论文
共 50 条
  • [21] Interactions between Beta-Amyloid and Pericytes in Alzheimer's Disease
    Li, You-Yue
    Guo, Dan -Dan
    Duan, Ruo-Nan
    Li, Yi
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (04):
  • [22] Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease
    Cai, Zhiyou
    Hussain, M. Delwar
    Yan, Liang-Jun
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2014, 124 (05) : 307 - 321
  • [23] Beta-amyloid cuproprotein: A therapeutic target for Alzheimer's disease
    Bush, AI
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2003, 96 (01) : 43 - 43
  • [24] Membrane rafts in Alzheimer's disease beta-amyloid production
    Vetrivel, Kulandaivelu S.
    Thinakaran, Gopal
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2010, 1801 (08): : 860 - 867
  • [25] Progranulin and beta-amyloid: A mew mechanism for Alzheimer's disease?
    Gruber, Stacey
    Rosso, Andrea
    Lippa, Carol
    NEUROLOGY, 2008, 70 (11) : A330 - A330
  • [26] The role of beta-amyloid deposition in the progression of Alzheimer's disease
    Hock, C.
    Nitsch, R. M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 23 - 23
  • [27] The subcellular neuropathology of Alzheimer's beta-amyloid
    Gouras, GK
    Li, F
    Takahashi, RH
    NEUROLOGY, 2002, 58 (07) : A364 - A364
  • [28] CSF beta-amyloid, cognition, and APOE genotype in Alzheimer's disease
    Samuels, SC
    Silverman, JM
    Marin, DB
    Peskind, ER
    Younki, SG
    Greenberg, DA
    Schnur, E
    Santoro, J
    Davis, KL
    NEUROLOGY, 1999, 52 (03) : 547 - 551
  • [29] Investigating the effects of beta-amyloid on hippocampal signalling in Alzheimer's disease
    Julia M Warburton
    Daniel J Whitcomb
    Krasimira Tsaneva-Atanasova
    Kei Cho
    BMC Neuroscience, 16 (Suppl 1)
  • [30] Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease
    Braak, H
    Braak, E
    Bohl, J
    Reintjes, R
    NEUROSCIENCE LETTERS, 1996, 210 (02) : 87 - 90